Sort   by:  
 Page size 
UnknownEducation: An overview from the author of 'Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-negative infections in intensive care unit patients'.
Not available
S-EPMC8251248 | biostudies-literature
UnknownLiquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib.
Not available
S-EPMC6826724 | biostudies-literature
UnknownTriplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).
Not available
S-EPMC3322957 | biostudies-literature
UnknownPretomanid for tuberculosis treatment: an update for clinical purposes.
Not available
S-EPMC9461242 | biostudies-literature
UnknownPhenotypic and Molecular Characterization of Pyomelanin-Producing <i>Acinetobacter baumannii</i> ST2<sub>Pas</sub>;ST1816/ST195<sub>Oxf</sub> Causing the First European Nosocomial Outbreak.
Not available
S-EPMC11945678 | biostudies-literature
UnknownImmune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis.
Not available
S-EPMC8264334 | biostudies-literature
UnknownNon-small-cell lung cancer: how to manage BRAF-mutated disease.
Not available
S-EPMC10166262 | biostudies-literature
UnknownWhat have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group.
Not available
S-EPMC8590524 | biostudies-literature
UnknownA Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid Tumors.
Not available
S-EPMC7352719 | biostudies-literature
UnknownThe appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisal.
Not available
S-EPMC6822439 | biostudies-literature
Sort   by:  
 Page size